These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

231 related items for PubMed ID: 2108852

  • 21. The risk of stroke in patients with acute myocardial infarction after thrombolytic and antithrombotic treatment. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico II (GISSI-2), and The International Study Group.
    Maggioni AP, Franzosi MG, Santoro E, White H, Van de Werf F, Tognoni G.
    N Engl J Med; 1992 Jul 02; 327(1):1-6. PubMed ID: 1598096
    [Abstract] [Full Text] [Related]

  • 22. Unfractionated and low-molecular-weight heparin as adjuncts to thrombolysis in aspirin-treated patients with ST-elevation acute myocardial infarction: a meta-analysis of the randomized trials.
    Eikelboom JW, Quinlan DJ, Mehta SR, Turpie AG, Menown IB, Yusuf S.
    Circulation; 2005 Dec 20; 112(25):3855-67. PubMed ID: 16344381
    [Abstract] [Full Text] [Related]

  • 23. Streptokinase-induced hypotension has no detrimental effect on patients with thrombolytic treatment for acute myocardial infarction. A substudy of the Romanian Study for Accelerated Streptokinase in Acute Myocardial Infarction (ASK-ROMANIA).
    Tatu-Chiţoiu G, Teodorescu C, Dan M, Guran M, Căpraru P, Istrăţescu O, Tatu-Chiţoiu A, Bumbu A, Chioncel V, Arvanitopol S, Dorobanţu M.
    Rom J Intern Med; 2004 Dec 20; 42(3):557-73. PubMed ID: 16366130
    [Abstract] [Full Text] [Related]

  • 24. [Anisoylated plasminogen streptokinase complex during the acute phase of myocardial infarction. Results of a multicenter double-blind study versus heparin].
    Cassagnes J, Bassand JP, Machecourt J, Lusson JR, Anguenot T, Borel E, Vacher D, Denis B, Maurat JP, Jallut H.
    Arch Mal Coeur Vaiss; 1990 Apr 20; 83(4):453-60. PubMed ID: 2111665
    [Abstract] [Full Text] [Related]

  • 25. [The prevention of reocclusion after thrombolysis in acute myocardial infarct: is tissue-type plasminogen activator really superior to streptokinase?].
    Negrini M.
    G Ital Cardiol; 1995 Apr 20; 25(4):511-5. PubMed ID: 7677921
    [No Abstract] [Full Text] [Related]

  • 26. Thrombolytic therapy in acute MI. Weighing the risks and benefits.
    Ro KG, Anderson HV.
    Postgrad Med; 1990 Dec 20; 88(8):79-80, 83-6, 89-90 passim. PubMed ID: 2123035
    [Abstract] [Full Text] [Related]

  • 27. Thrombolytic therapy in acute myocardial infarction: an emergency department perspective.
    Walters BL.
    Henry Ford Hosp Med J; 1991 Dec 20; 39(3-4):184-94. PubMed ID: 1687142
    [No Abstract] [Full Text] [Related]

  • 28. New developments in thrombolytic therapy.
    Collen D, Gold HK.
    Adv Exp Med Biol; 1990 Dec 20; 281():333-54. PubMed ID: 2129372
    [Abstract] [Full Text] [Related]

  • 29. Coronary thrombolysis: round two and beyond.
    Wilcox RG.
    Br Heart J; 1991 Apr 20; 65(4):175-6. PubMed ID: 1903042
    [No Abstract] [Full Text] [Related]

  • 30. Early intravenous beta-blocker combined with thrombolytic therapy for acute myocardial infarction: the Thrombolysis in Myocardial Infarction (TIMI-2) Trial.
    Borzak S, Gheorghiade M.
    Prog Cardiovasc Dis; 1993 Apr 20; 36(3):261-6. PubMed ID: 8234778
    [No Abstract] [Full Text] [Related]

  • 31. Thrombolysis in acute myocardial infarction: analysis of studies comparing accelerated t-PA and streptokinase.
    Smith BJ.
    J Accid Emerg Med; 1999 Nov 20; 16(6):407-11. PubMed ID: 10572811
    [Abstract] [Full Text] [Related]

  • 32. Thrombolysis and adjunctive therapy in acute myocardial infarction: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.
    Menon V, Harrington RA, Hochman JS, Cannon CP, Goodman SD, Wilcox RG, Schünemann HJ, Ohman EM.
    Chest; 2004 Sep 20; 126(3 Suppl):549S-575S. PubMed ID: 15383484
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Intravenous thrombolytic therapy in myocardial infarction: an analytical review.
    Shammas NW, Zeitler R, Fitzpatrick P.
    Clin Cardiol; 1993 Apr 20; 16(4):283-92. PubMed ID: 8458108
    [Abstract] [Full Text] [Related]

  • 35. [Comparison of clinical efficacy of thrombolytic drugs in patients with acute myocardial infarction].
    López-Sendón JL.
    Rev Esp Cardiol; 1992 Apr 20; 45 Suppl 2():9-20. PubMed ID: 1475514
    [Abstract] [Full Text] [Related]

  • 36. Routine medical management of acute myocardial infarction. Lessons from overviews of recent randomized controlled trials.
    Yusuf S, Sleight P, Held P, McMahon S.
    Circulation; 1990 Sep 20; 82(3 Suppl):II117-34. PubMed ID: 1975522
    [Abstract] [Full Text] [Related]

  • 37. Is there an age limit for thrombolytic therapy?
    Sleight P.
    Am J Cardiol; 1993 Dec 16; 72(19):30G-33G. PubMed ID: 8279358
    [Abstract] [Full Text] [Related]

  • 38. Aspirin augmentation of the efficacy of thrombolysis.
    O'Donnell CJ, Jonas MA, Hennekens CH.
    Coron Artery Dis; 1995 Dec 16; 6(12):936-9. PubMed ID: 8723015
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Thrombolytic therapy for acute myocardial infarction.
    Bates ER, Topol EJ.
    Chest; 1989 May 16; 95(5 Suppl):257S-264S. PubMed ID: 2523296
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.